On the banner, the words “Professionalism forges quality, service wins reputation” are particularly prominent. In just twelve words, it condensed the recognition and affirmation of KCI by Chunhai Biology.
In addition to the banner, Ms. Li also expressed her recognition of the pharmacological and pharmacodynamic services provided by KCI and her gratitude to all colleagues, and took a friendly photo with colleagues from the in vivo pharmacology department.
Ms. Li, the R&D leader of Chunhai Biotechnology, presented a banner to KCI BioTech
Colleagues from the Department of Biopharmaceuticals at KCI pose for a photo with Jinqi
About KCI BioTech (Suzhou) Inc.
KCI BioTech (Suzhou) Inc. and its wholly-owned subsidiary Jiangsu KMQ BioTech Inc. are committed to providing comprehensive preclinical new drug research and development services to global pharmaceutical companies and research institutions, and establishing a professional and efficient drug research and development evaluation system.KCI KMQ has two internationally advanced experimental animal facilities in Suzhou and Nantong, both of which have obtained international AAALAC certification, with a total area of over 18000 square meters; We have established a full range of experimental animal platforms including mice, hamsters, guinea pigs, rabbits, cats, dogs, pigs, ferrets, and non-human primates, over 400 animal models of tumors and non tumor diseases, ABSL-2/BSL-2 anti infective drug and vaccine evaluation experimental platforms, pathology, early toxicology cell and molecular biology, pharmacokinetics, medical imaging, and other research service platforms.
